Document Detail

Usefulness and applicability of femorofemoral crossover bypass grafting.
MedLine Citation:
PMID:  18640814     Owner:  NLM     Status:  MEDLINE    
We examined the usefulness of femorofemoral crossover bypass grafting (FFC) and factors influencing its outcome by retrospectively analyzing all FFCs performed in our hospital over a 5-year period, focusing on both patency rates and clinical efficacy. For 95 patients Kaplan-Meier patency rates were calculated (follow-up 40.4 +/- 3.0 months). Clinical outcome was defined according to Rutherford's standardized categories. The influence of cardiovascular risk factors and technical characteristics on outcome was determined. Clinical status of the limb remained improved in 89%. One- and 5-year primary, primary assisted, and secondary patency rates were 88.2% and 57.3%, 90.6% and 62.4%, and 92.6% and 68.1%, respectively. Clinical outcome of the limb was better in patients with <50% stenosis in the femoral arteries preoperatively (p = 0.033). No predictors for patency rates were identified. FFCs are effective in the medium long term for patients in all age categories independently of cardiovascular risk factors. The best predictor of clinical outcome is the preoperative degree of stenosis, with a better outcome for patients affected by <50% stenosis. Success of FFC cannot be reliably measured by graft patency alone but should be assessed by combining patency rates and clinical outcome according to standardized categories.
Geertje Thuijls; L W van Laake; M S Lemson; P J Kitslaar
Related Documents :
19672124 - Survival of corneal allografts following topical treatment with the immunomodulator myc...
23252444 - Safety and feasibility of physical therapy in cytopenic patients during allogeneic haem...
8322124 - Urokinase therapy for thrombosed hemodialysis access grafts.
25089174 - A comparative clinical evaluation of the effect of preoperative and postoperative antim...
15647184 - Frequency and significance of granulomas in a cohort of incident cases of crohn's disease.
22690824 - Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-m...
Publication Detail:
Type:  Journal Article     Date:  2008-07-21
Journal Detail:
Title:  Annals of vascular surgery     Volume:  22     ISSN:  1615-5947     ISO Abbreviation:  Ann Vasc Surg     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-09-01     Completed Date:  2008-11-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703941     Medline TA:  Ann Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  663-7     Citation Subset:  IM    
Department of Surgery, University Hospital of Maastricht, Maastricht, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arterial Occlusive Diseases / physiopathology,  surgery*
Blood Vessel Prosthesis
Blood Vessel Prosthesis Implantation* / adverse effects,  instrumentation
Constriction, Pathologic
Femoral Artery / physiopathology,  surgery*
Middle Aged
Prosthesis Design
Retrospective Studies
Severity of Illness Index
Time Factors
Treatment Outcome
Vascular Patency*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Management of upper extremity arterial injuries at an urban level I trauma center.
Next Document:  Effects of acute global venous obstruction and unfractionated heparin on muscle cytokine synthesis.